Loading…

Functional peptide KP24 enhances submandibular gland tissue growth in vitro

Salivary gland hypofunction, also known as xerostomia, occurs as a result of radiotherapy for head and neck cancer, autoimmune diseases, or aging. Xerostomia leads to oral health problems and thus affects the quality of life. Biological salivary gland tissue generated in vitro would provide an alter...

Full description

Saved in:
Bibliographic Details
Published in:Regenerative therapy 2016-03, Vol.3 (C), p.108-113
Main Authors: Ikeda, Atsushi, Taketa, Hiroaki, Sathi, Gulsan Ara, Hirano, Yoshiaki, Iida, Seiji, Matsumoto, Takuya
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Salivary gland hypofunction, also known as xerostomia, occurs as a result of radiotherapy for head and neck cancer, autoimmune diseases, or aging. Xerostomia leads to oral health problems and thus affects the quality of life. Biological salivary gland tissue generated in vitro would provide an alternative mode of treatment for this disease. To develop a novel method for modulating salivary gland tissue growth in vitro, we prepared a KP24 peptide-immobilized hydrogel sheet, wherein the peptide comprised repeating proline and lysine sequences, and evaluated the effect of this peptide on salivary gland tissue growth. We found that the KP24 peptide has the potential to enhance glandular tissue growth in vitro. This enhancement is associated with neurite outgrowth and increasing neural innervation. KP24 peptide modified material would be a promising material for the modulation of salivary gland tissue growth in vitro. •KP24 immobilized hydrogel enhanced the growth of submandibular gland tissue in vitro.•KP24 immobilized hydrogel is related to the neuronal innervasion and neurite outgrowth in growing submandibular gland tissue.
ISSN:2352-3204
2352-3204
DOI:10.1016/j.reth.2016.02.006